TY - JOUR T1 - <span hwp:id="article-title-1" class="article-title">Review: vaccines against human papillomavirus prevent cervical cancer precursors in young women</span><span hwp:id="article-title-2" class="sub-article-title">Commentary</span> JF - Evidence Based Nursing JO - Evid Based Nurs SP - 11 LP - 11 DO - 10.1136/ebn.11.1.11 VL - 11 IS - 1 AU - Jacqueline Muresan Y1 - 2008/01/01 UR - http://ebn.bmj.com/content/11/1/11.abstract N2 - L RamboutCorrespondence to: Ms L Rambout, Ottawa Hospital, Ottawa, Ontario, Canada; lrambout@ottawahospital.on.caDo vaccines against human papillomavirus (HPV) prevent cervical cancer precursors in young women?Data sources:Medline and EMBASE/Excerpta Medica (to May 2007); Medline in process (to June 2007); Cochrane Library and Cochrane Central Register of Controlled Trials (Issue 1, 2007); conference proceedings (2004–7); clinical trial registers; Google Scholar; public health announcements; reference lists; and vaccine manufacturers.Study selection and assessment:randomised controlled trials (RCTs) that compared a vaccine against ⩾1 oncogenic type of HPV with placebo or no HPV vaccine for prophylaxis of oncogenic HPV-related infection and disease in women. 9 reports of 6 RCTs (n = 40 323; mean age 20 y, range 15–26 y) met the selection criteria. 1 RCT (n = 2392) evaluated a monovalent HPV 16 vaccine, 2 RCTs … ER -